Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Journal of the American Society of Nephrology : JASN|June 1, 1992
Lymphoproliferative disorders after renal transplantation in patients receiving triple or quadruple immunosuppressionB Melosky, M Karim, A Chui, et al.Current Oncology (Toronto, Ont.)|December 31, 2020
Consensus recommendations for optimizing biomarker testing to identify and treat advanced EGFR-mutated non-small-cell lung cancerP K Cheema, M Gomes, S Banerji, et al.Current Oncology (Toronto, Ont.)|January 5, 2017
Treatment patterns and survival in patients with ALK-positive non-small-cell lung cancer: a Canadian retrospective studyS Kayaniyil, M Hurry, J Wilson, et al.Current Oncology (Toronto, Ont.)|March 7, 2018
Standardizing biomarker testing for Canadian patients with advanced lung cancerB Melosky, N Blais, P Cheema, et al.Current Oncology (Toronto, Ont.)|February 21, 2009
The role of the epidermal growth factor receptor tyrosine kinase inhibitors as therapy for advanced, metastatic, and recurrent non-small-cell lung cancer: a Canadian national consensus statementP M Ellis, W Morzycki, B Melosky, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Phase I study of liposomal vincristineK A Gelmon, A Tolcher, A R Diab, et al.Current Oncology (Toronto, Ont.)|May 3, 2019
A network approach to developing immuno-oncology combinations in CanadaV Higenell, R Fajzel, G Batist, et al.Current Oncology (Toronto, Ont.)|June 23, 2016
Canadian consensus: inhibition of ALK-positive tumours in advanced non-small-cell lung cancerB Melosky, J Agulnik, R Albadine, et al.Current Oncology (Toronto, Ont.)|November 23, 2018
Canadian perspectives: update on inhibition of ALK-positive tumours in advanced non-small-cell lung cancerB Melosky, P Cheema, J Agulnik, et al.Current Oncology (Toronto, Ont.)|September 25, 2019
Crizotinib inhibition of ROS1-positive tumours in advanced non-small-cell lung cancer: a Canadian perspectiveD G Bebb, J Agulnik, R Albadine, et al.Pageof 4